当前位置：
X-MOL 学术
›
Ann. Clin. Biochem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab.
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine ( IF 2.1 ) Pub Date : 2019-12-27 , DOI: 10.1177/0004563219894354 Sally Thirkettle 1 , Joanne Russell 1 , Sarah Wilson 1 , Tasneem Ganijee 2 , Samar Kulkarni 2 , Jim Cavet 2, 3 , Phillip J Monaghan 1, 4
中文翻译：
对监测正在接受抗CD38单克隆daratumumab治疗的多发性骨髓瘤患者的意义。
更新日期：2019-11-01
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine ( IF 2.1 ) Pub Date : 2019-12-27 , DOI: 10.1177/0004563219894354 Sally Thirkettle 1 , Joanne Russell 1 , Sarah Wilson 1 , Tasneem Ganijee 2 , Samar Kulkarni 2 , Jim Cavet 2, 3 , Phillip J Monaghan 1, 4
Affiliation
中文翻译：
对监测正在接受抗CD38单克隆daratumumab治疗的多发性骨髓瘤患者的意义。
京公网安备 11010802027423号